Exploring Prevention Strategies for Respiratory Syncytial Virus in Older Adults: A Podcast Series

1.00 CME
1.00 CME with ABIM MOC
$0 FEE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patient in wheelchair with oxygen


Provider Statement

This continuing medical education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Activity Description

Respiratory syncytial virus (RSV) is a highly prevalent respiratory infection and a leading cause of bronchitis and pneumonia. Although most cases manifest clinically as mild-to-moderate upper respiratory disease, severe sequelae can occur in high-risk individuals. RSV infections can be particularly dangerous for older and immunocompromised adults, leading to complications such as pneumonia and worsening of chronic cardiopulmonary disease. In this Expert Exchange podcast series, faculty will examine the burden of RSV infection in older adults, risk factors for severe disease, diagnostic challenges, and strategies for preventing RSV in older adults—highlighting recent evidence for vaccines in late-stage development.

Target Audience

The intended audience for this activity is family medicine physicians, internists, nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with or at-risk for respiratory syncytial virus (RSV).

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Assess the prevalence and burden of respiratory syncytial virus (RSV) infection in older adults, including complications and risk factors for progression of the disease.
  • Evaluate diagnostic criteria, challenges, and tools for the differential diagnosis of RSV in older adults.
  • Describe modalities to enhance the awareness of the disease state and prevention of RSV.
  • Examine the evidence for investigational vaccines for the prevention of RSV infection in older adults.

Activity Chair

Neil S. Skolnik, MD, FAAFP
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
Associate Director
Family Medicine Residency Program
Abington – Jefferson Health
Abington, PA


Stefan A. Gravenstein, MD, MPH
David S. Greer Professor of Geriatric Medicine
Director, Division of Geriatrics and Palliative Care
Professor of Health Services Policy and Practice Warren Alpert Medical School
Brown University
Providence, RI

Michael G. Ison, MD, MS, FIDSA, FAST
Professor, Divisions of Infectious Diseases and Organ Transplantation
Northwestern University Feinberg School of Medicine
Medical Director, Transplant and Immunocompromised Host Infectious Diseases Service
Northwestern University Comprehensive Transplant Center
Chicago, IL


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

abimSuccessful completion of this CME activity enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants who opt-in by providing their ABIM ID and DOB (MM/DD) will earn MOC points equivalent to the amount of CME credits claimed for the activity.

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.0 hours credit for completing this program.

This enduring material is approved for 1 year from the date of original release, June 21, 2022, to June 20, 2023.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, listen to the podcasts, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.


Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant relationship(s)

Stefan A. Gravenstein, MD, MPH
Advisor: Genentech, Janssen, Novavax, Pfizer, Reviral, Sanofi, Vaxart
Consultant: Genentech, Janssen, Moderna, Reviral, Sanofi, Vaxart
Speaker Contracted by Ineligible Company: Janssen
Independent Research Contractor: Genentech, Pfizer, Sanofi

Michael G. Ison, MD, MS, FIDSA, FAST
Royalties or Patent Beneficiary: UpToDate
Consultant: ADMA Biologics, AlloVir, Atea, Cidara, Genentech/Roche, Janssen, Viracor Eurofins
Independent Research Contractor: GlaxoSmithKline

Neil S. Skolnik, MD, FAAFP
Consultant: Abbott, AstraZeneca, Genentech, GlaxoSmithKline, Sanofi, Sanofi Pasteur
Speaker Contracted by Ineligible Company: AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline
Independent Research Contractor: AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Novo Nordisk, Sanofi

Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

ADA Disclaimer

In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this Podcast is available upon request. Requests should include the Podcast title and can be emailed to cme@vindicoCME.com. Requests will be honored within 3-5 business days.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at cme@vindicoCME.com